NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for VS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stabilize management team | A supporting condition in VERSUS SYSTEMS INC's published investment case. The stated target is No major executive departures in next 4 quarters. | Improving | Unexpected key executive departures occur | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
VS is a high-risk, loss-making company with signs of a turnaround, rather than an established compounder. Its thesis is in a watch state, and confidence is low because recent performance remains below its industry cohort.
The valuation model indicates VS is expensive versus peers, with a 4.75 premium, though confidence in that estimate is low. The evidence points to some expectations around future opportunity, but does not show that the market has priced in a strong business recovery.
Near-term, execution is mixed: operating and net income improved through 2026-Q2, but revenue fell from 2026-Q1 and the strategic partnership has yet to show much revenue impact. The company also improved stockholders’ equity above the stated Nasdaq minimum by 2026-Q2, while listing and capital-allocation events remain risks.
Over the next few years, the thesis hinges on whether improved earnings continue and partnerships begin to add revenue. Near-term conditions could help if interest rates ease or major technology companies stabilize, while materially slower economic growth could weigh more heavily on VS.
The 1-to-3-year view is a tentative turnaround case, supported by improving earnings but constrained by weak revenue, high risk, and low confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Versus Systems can improve its financial health by reversing its sharp revenue drop. |
| Intact |
| Net losses do not decrease or worsen over the next 4 quarters |
Net income: $473,297 FY2026-Q2; GAAP. Published target: Net losses decrease by at least 20% year over year. Target and observation units differ. Aug 14, 2026473,297 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 quarters from 2025-Q3 through 2026-Q2. Operating income improved significantly from -$1.17M in 2025-Q4 to $594K in 2026-Q2, and net income turned positive from -$965K to $473K in the same period. This shows delivering progress on financial performance improvement. Delivery assessment Oct 31, 2026 |
Revenue improves from the 2026-Q1 trough | A primary condition in VERSUS SYSTEMS INC's published investment case. The stated target is Revenue > $1,000,000 next 4 quarters. | Intact | Revenue remains below $1,000,000 over the next 4 quarters | Revenue: $6,821 FY2026-Q2; GAAP. Published target: Revenue > $1,000,000 next 4 quarters. Target period is not explicitly aligned with this observation. Aug 14, 20266,821 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 quarters from 2025-Q3 through 2026-Q2. Operating income improved significantly from -$1.17M in 2025-Q4 to $594K in 2026-Q2, and net income turned positive from -$965K to $473K in the same period. This shows delivering progress on financial performance improvement. Delivery assessment Oct 31, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.